captopril has been researched along with ketanserin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Coffman, JD | 1 |
| Barbara, C; Bruzzone, F; Canale, C; Masperone, MA; Provinciali, L; Romeo, M; Terrachini, V; Zanna, C | 1 |
| Buczko, W; Chabielska, E; Malinowska, B; Pietraszek, MH | 1 |
| Assogna, G; Ladetto, PE; Lavezzaro, G; Salvetti, A; Stramignoni, D; Valente, M; Zanna, C | 1 |
| Buczko, W; Malinowska, B | 1 |
| Lazareth, I | 1 |
| Meyer, P; Safar, M | 1 |
| McGoon, MD; Vlietstra, RE | 1 |
| Glusa, E | 1 |
2 review(s) available for captopril and ketanserin
| Article | Year |
|---|---|
Raynaud's phenomenon. An update.
Topics: Calcium Channel Blockers; Captopril; Humans; Ketanserin; Prostaglandins; Raynaud Disease; Sympatholytics | 1991 |
Vasodilator therapy for primary pulmonary hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Blood Pressure; Calcium Channel Blockers; Captopril; Epoprostenol; Hemodynamics; Humans; Hypertension, Pulmonary; Ketanserin; Piperidines; Serotonin Antagonists; Vascular Resistance; Vasodilator Agents | 1984 |
3 trial(s) available for captopril and ketanserin
| Article | Year |
|---|---|
[Short and medium term evaluation of captopril-ketanserin combination in mild to moderate arterial hypertension].
Topics: Adult; Aged; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Ketanserin; Male; Middle Aged; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Ketanserin and captopril interaction in the treatment of essential hypertensives.
Topics: Adult; Aldosterone; Blood Pressure; Body Weight; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Ketanserin; Male; Middle Aged; Potassium; Sodium | 1990 |
Comparison of ketanserin with captopril in older hypertensives. A double-blind randomised trial.
Topics: Aged; Aged, 80 and over; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Humans; Hypertension; Ketanserin; Middle Aged; Multicenter Studies as Topic; Random Allocation | 1988 |
11 other study(ies) available for captopril and ketanserin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The serotonergic mechanisms are not involved in the inhibitory effect of captopril on rat platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Captopril; Collagen; Ketanserin; Male; Platelet Aggregation; Rats; Rats, Inbred Strains; Serotonin | 1990 |
Influence of captopril on the vasopressor effect of serotonin in pithed rats.
Topics: Animals; Arteries; Blood Pressure; Captopril; Decerebrate State; Dose-Response Relationship, Drug; Ketanserin; Male; Rats; Rats, Inbred Strains; Regional Blood Flow; Serotonin; Tail | 1989 |
[Treatment of Raynaud's phenomenon].
Topics: Adrenergic alpha-Antagonists; Calcium Channel Blockers; Captopril; Humans; Ketanserin; Prostaglandins; Raynaud Disease | 1987 |
Desulfated hirugen (hirudin 54-65) induces endothelium-dependent relaxation of porcine pulmonary arteries.
Topics: 1-Methyl-3-isobutylxanthine; Amino Acid Sequence; Animals; Arginine; Atropine; Bradykinin; Calcium; Captopril; Cyclic GMP; Dinoprost; Endothelium, Vascular; Hirudins; Histamine; Indomethacin; Ketanserin; Methiothepin; Molecular Sequence Data; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Peptide Fragments; Phentolamine; Pulmonary Artery; Swine; Vasodilation | 1994 |